GATEHOUSE BIO
Gatehouse Bio is a biotech company developing effective therapeutics using AI that harnesses the power of small RNA. Their platform discovers disease-associated mutations and designs therapeutics to counteract their effect. We believe there is an RNA code that can treat every disease Our mission is to find that code and use it to develop effective therapeutics Our platform uses AI to discover mutations in small RNA genes and design oligonucleotides that crack a disease’s code Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity (Fibrosis, Inflammation, Neurodegeneration) With every single code we break, we unlock the potential to improve the lives of many
GATEHOUSE BIO
Social Links:
Industry:
Biotechnology
Founded:
2018-04-16
Website Url:
http://www.gatehousebio.com
Total Employee:
11+
Status:
Active
Contact:
408-439-8967
Email Addresses:
[email protected]
Total Funding:
7.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited is a Biotechnology Company.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Just - Evotec Biologics
Designing innovative technologies focused on accelerating global access to biotherapeutics.
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
IndieBio
IndieBio investment in Convertible Note - Gatehouse Bio
SOSV
SOSV investment in Convertible Note - Gatehouse Bio
SOSV
SOSV investment in Seed Round - Gatehouse Bio
IndieBio
IndieBio investment in Seed Round - Gatehouse Bio
IndieBio
IndieBio investment in Series A - Gatehouse Bio
SOSV
SOSV investment in Series A - Gatehouse Bio
Front Row Fund
Front Row Fund investment in Seed Round - Gatehouse Bio
SOSV
SOSV investment in Seed Round - Gatehouse Bio
IndieBio
IndieBio investment in Seed Round - Gatehouse Bio
Official Site Inspections
http://www.gatehousebio.com Semrush global rank: 4.79 M Semrush visits lastest month: 1.91 K
- Host name: 187.81.197.104.bc.googleusercontent.com
- IP address: 104.197.81.187
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Gatehouse Bio"
Gatehouse Bio - Crunchbase Company Profile & Funding
Gatehouse Bio is a biotech company developing effective therapeutics using AI that harnesses the power of small RNA. Their platform discovers disease-associated mutations and designs …See details»
Gatehouse Bio Company Profile 2024: Valuation, …
Gatehouse Bio General Information Description. Developer of a Ribonucleic Acid analytics platform designed to classify patient samples with binary accuracy. The company's platform identifies small RNA biomarkers discovers molecular …See details»
Gatehouse Bio - LinkedIn
Gatehouse Bio is a TechBio company decoding small RNA (sRNA) isoforms to develop biomarker-guided precision oligonucleotide therapeutics.See details»
Contact Us - Gatehouse Bio
As founder and CEO of Gatehouse Bio, David has over 14 years of research expertise and experience in microRNA and sRNA biology. He is the force behind the science and …See details»
David W. Salzman - Founder & CEO - Gatehouse Bio | LinkedIn
Founder & CEO of Gatehouse Bio · Proficient and entrepreneurial scientist with a proven success record in increasing portfolio value through the conceptualization, discovery, …See details»
Gatehouse Bio - Company info. interviews, news - BiopharmaTrend
Dec 29, 2022 https://www.gatehousebio.com. Founded 2016. Patents 1. Technologies AI Companies (Drug Discovery) Gene Therapy Startups RNA-focused Startups. Gatehouse Bio’s …See details»
sRNA research and insights - Gatehouse Bio
As founder and CEO of Gatehouse Bio, David has over 14 years of research expertise and experience in microRNA and sRNA biology. He is the force behind the science and …See details»
Gatehouse Bio - VentureRadar
"Gatehouse Bio's Code-Breaker™ platform uses AI to decode the landscape of small RNAs (sRNAs) and digitally design biomarker-guided precision oligonucleotide therapeutics.See details»
Gatehouse Bio | VentureRadar
Website: https://gatehousebio.com/ Develops AI-based platform to decode small RNAs, designing biomarker-guided precision therapeutics for pulmonary, cardiac ...See details»
Gatehouse Bio Inc Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. ... gatehousebio.com. View Complete Information. Hot Search Keywords for Gatehouse Bio Inc. …See details»
Gatehouse Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
For more information visit and follow us on Twitter @gatehousebio. Collaborate Oligonucleotide. 100 Deals associated with Gatehouse Bio, Inc. Login to view more data. ... The statistics for …See details»
Gatehouse Bio - Overview, News & Similar companies - ZoomInfo
Gatehouse Bio Announces Upcoming Presentation at RNA Leaders Europe Congress BOSTON--(BUSINESS WIRE)--Gatehouse Bio, a TechBio company utilizing AI to decode the landscape …See details»
Gatehouse Bio - VentureRadar
Gatehouse Bio's Code-Breaker™ platform uses AI to decode the landscape of small RNAs (sRNAs) and digitally design biomarker-guided precision... ... Find out more ...See details»
Gatehouse Bio Extends Its Partnership with AstraZeneca to …
Sep 8, 2022 BOSTON--(BUSINESS WIRE)--Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are …See details»
Gatehouse Bio Announces Upcoming Presentation at RNA Leaders …
Mar 13, 2023 BOSTON--(BUSINESS WIRE)--Gatehouse Bio, a TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and digitally design precision oligonucleotide …See details»
News & Publications - Gatehouse Bio
Feb 28, 2019 News and Publications Press Releases Publications We also partner with a disease-specific advisory board of researchers and clinicians who support neurological, …See details»
Gatehouse Bio Extends Its Partnership with AstraZeneca to
Sep 8, 2022 BOSTON--(BUSINESS WIRE)-- Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are …See details»
Gatehouse Bio collaborates with AstraZeneca to accelerate new …
Dec 4, 2019 BOSTON--(BUSINESS WIRE)--Gatehouse Bio, a pioneer in next-generation therapeutics, is collaborating with AstraZeneca, a global science-led biopharmaceutical …See details»
Gatehouse Bio Extends Its Partnership with AstraZeneca to …
Sep 9, 2022 Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA …See details»